Qiang Wei

40PUBLICATIONS
52CO-AUTHORS
Environmental epidemiologyPacific Peoples sport and physical activityMolecular targetsTraditional Chinese medicine and treatmentsDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Jul 30, 2026
Environmental exposome study for prostate cancer in elderly men from Western China: preliminary findings from a case-control study in the WeEndPd cohort.

|Jun 29, 2026
[Mid- to Long-Term Urinary Continence Outcomes of Pelvic-Peritoneal Structure-Sparing Techniquein Robot-Assisted Radical Prostatectomy].

|Nov 15, 2025
Immune checkpoint inhibitor nivolumab induces durable response in microsatellite instability-high and DNA damage repair-deficient metastatic castration-resistant prostate cancer.

Guofa Lu, Jinbao Wang, Weitao Zheng

|Oct 05, 2024
Androgen-ablative therapies inducing CXCL8 regulates mTORC1/SREBP2-dependent cholesterol biosynthesis to support progression of androgen receptor negative prostate cancer cells.

Xingyu Xiong, Shiyu Zhang, Weizhen Zhu

|Jul 17, 2024
Acupuncture: a promising adjuvant strategy for pain management among the patients with prostate cancer.

Jie Yang, Xingyu Xiong, Qiang Wei

|Jun 14, 2024
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer.

Bo Chen, Pengfei Xu, Joy C Yang

Pageof 7

Frequent Collaborators

12 joint publications

Lu Yang

3 joint publications

Ping Tan

3 joint publications

Shi Qiu

2 joint publications

Joy Yang